123 related articles for article (PubMed ID: 3665207)
1. Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes.
Solerte SB; Fioravanti M
Clin Nephrol; 1987 Sep; 28(3):138-43. PubMed ID: 3665207
[TBL] [Abstract][Full Text] [Related]
2. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
[TBL] [Abstract][Full Text] [Related]
4. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
Komers R; Malý J; Simková R
Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
[TBL] [Abstract][Full Text] [Related]
5. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
Weinrauch LA; Gleason RE; Keough J; D'Elia JA
Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
[TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy in insulin-dependent diabetes mellitus: pathogenesis and treatment strategies.
Bilo HJ; Gans RO; Elving L; de Nobel E; Donker AJ
Neth J Med; 1990 Feb; 36(1-2):74-85. PubMed ID: 2179753
[TBL] [Abstract][Full Text] [Related]
8. The renal hemodynamic basis of diabetic nephropathy.
O'Bryan GT; Hostetter TH
Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
[TBL] [Abstract][Full Text] [Related]
9. Glomerular hyperfiltration and blood viscosity in type I (insulin-dependent) diabetic subjects.
Ditzel J
Diabete Metab; 1984 Jan; 10(1):7-11. PubMed ID: 6724100
[TBL] [Abstract][Full Text] [Related]
10. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
11. Blood and plasma viscosity in diabetes: possible contribution to late organ complications?
Schut NH; van Arkel EC; Hardeman MR; Bilo HJ; Michels RP; Vreeken J
Diabetes Res; 1992 Jan; 19(1):31-5. PubMed ID: 1468184
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus: its effect on the flow properties of blood.
Oughton J; Barnes AJ; Kohner EM
Horm Metab Res Suppl; 1981; 11():112-20. PubMed ID: 6797911
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
Solerte SB; Piovella F; Viola C; Schianca GC; Gamba G; Fioravanti M; Ferrari E
Acta Diabetol Lat; 1985; 22(3):239-46. PubMed ID: 3878055
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
[TBL] [Abstract][Full Text] [Related]
15. Differences between plasma viscosity and proteins of types 1 and 2 diabetic Africans in early phase of diabetes.
Memeh CU
Horm Metab Res; 1993 Jan; 25(1):21-3. PubMed ID: 8428705
[TBL] [Abstract][Full Text] [Related]
16. Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy.
Gordge MP; Patel A; Faint RW; Rylance PB; Neild GH
Diabet Med; 1990 Dec; 7(10):880-6. PubMed ID: 2149685
[TBL] [Abstract][Full Text] [Related]
17. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Björck S; Blohmé G; Sylvén C; Mulec H
Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
[TBL] [Abstract][Full Text] [Related]
18. Renal function changes in hypertensive patients with non-insulin- dependent diabetes mellitus.
Rius F; Pizarro E; Castells I; Salinas I; Sanmartí A; Romero R
Kidney Int Suppl; 1996 Jun; 55():S88-90. PubMed ID: 8743520
[TBL] [Abstract][Full Text] [Related]
19. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
20. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
